Goldman Sachs highlights tariff wars winners and losers

The primary beneficiaries of the tariffs include companies producing steel and aluminum, potentially improving their stock performance. Conversely, manufacturers that depend on these materials will likely see increased costs, impacting their profit margins and stock prices negatively. Investors in companies related to the latter industries should be cautious due to potential market disruptions driven by these tariff policies.

Pharmaceutical companies might face headwinds due to tariffs imposed on chemicals and pharmaceuticals, which would likely negatively affect their production and margins as inputs become more expensive. This could pressure shares of pharmaceutical companies.

With higher tariffs on imports affecting car prices, automotive companies could struggle, reflecting negatively on their stocks as production costs rise and consumer demand fluctuates. Investors should closely monitor any shifts in pricing power and demand among automakers.